uniQure

Performance

About uniQure

uniQure is a global biopharmaceutical company focused on developing gene therapies for serious genetic diseases, with a translational pipeline and manufacturing capabilities. The company emphasizes genomic medicine and innovative cures, particularly in neurodegenerative diseases such as Huntington’s disease, and maintains operations in Europe and the United States. Their work spans research programs, clinical trials, and partnerships to advance adeno-associated virus (AAV) platform therapies. uniQure positions itself as a leader in the field of gene therapy, driving science innovation and patient-focused initiatives.